Attention-deficit/hyperactivity disorder
Attention-deficit/hyperactivity disorder
Attention-deficit/hyperactivity disorder (ADHD) is a persistent neurodevelopmental disorder that affects 5% of children and adolescents and 2.5% of adults worldwide. Throughout an individual's lifetime, ADHD can increase the risk of other psychiatric disorders, educational and occupational failure, accidents, criminality, social disability and addictions. No single risk factor is necessary or sufficient to cause ADHD. In most cases ADHD arises from several genetic and environmental risk factors that each have a small individual effect and act together to increase susceptibility. The multifactorial causation of ADHD is consistent with the heterogeneity of the disorder, which is shown by its extensive psychiatric co-morbidity, its multiple domains of neurocognitive impairment and the wide range of structural and functional brain anomalies associated with it. The diagnosis of ADHD is reliable and valid when evaluated with standard criteria for psychiatric disorders. Rating scales and clinical interviews facilitate diagnosis and aid screening. The expression of symptoms varies as a function of patient developmental stage and social and academic contexts. Although there are no curative treatments for ADHD, evidenced-based treatments can markedly reduce its symptoms and associated impairments. For example, medications are efficacious and normally well tolerated, and various non-pharmacological approaches are also valuable. Ongoing clinical and neurobiological research holds the promise of advancing diagnostic and therapeutic approaches to ADHD
15020
Faraone, Stephen V.
bd307516-e8db-4d38-b649-9d7d7caafe93
Asherson, Philip
a734c1f6-f31a-450b-81c3-ba7bb373e147
Banaschewski, Tobias
4627c589-04cc-4f5b-ac2d-05f547f63dfd
Biederman, Joseph
fa82c04e-61be-40f5-824b-a5920ed3c9ed
Buitelaar, Jan K.
a2e08a14-4de4-419e-9ea8-1e97ebbdddba
Ramos-Quiroga, Josep Antoni
d88fffb7-683c-4f3f-bb34-84cbf209c062
Rohde, Luis Augusto
cd2ba2dc-686e-4ad4-9073-a9419846e8c8
Sonuga-Barke, Edmund J. S.
bc80bf95-6cf9-4c76-a09d-eaaf0b717635
Tannock, Rosemary
cfe9e585-dd98-400a-b51a-e4fb5d8305e8
Franke, Barbara
f71c8989-a108-40c4-a159-80a1e60b56bf
6 August 2015
Faraone, Stephen V.
bd307516-e8db-4d38-b649-9d7d7caafe93
Asherson, Philip
a734c1f6-f31a-450b-81c3-ba7bb373e147
Banaschewski, Tobias
4627c589-04cc-4f5b-ac2d-05f547f63dfd
Biederman, Joseph
fa82c04e-61be-40f5-824b-a5920ed3c9ed
Buitelaar, Jan K.
a2e08a14-4de4-419e-9ea8-1e97ebbdddba
Ramos-Quiroga, Josep Antoni
d88fffb7-683c-4f3f-bb34-84cbf209c062
Rohde, Luis Augusto
cd2ba2dc-686e-4ad4-9073-a9419846e8c8
Sonuga-Barke, Edmund J. S.
bc80bf95-6cf9-4c76-a09d-eaaf0b717635
Tannock, Rosemary
cfe9e585-dd98-400a-b51a-e4fb5d8305e8
Franke, Barbara
f71c8989-a108-40c4-a159-80a1e60b56bf
Faraone, Stephen V., Asherson, Philip, Banaschewski, Tobias, Biederman, Joseph, Buitelaar, Jan K., Ramos-Quiroga, Josep Antoni, Rohde, Luis Augusto, Sonuga-Barke, Edmund J. S., Tannock, Rosemary and Franke, Barbara
(2015)
Attention-deficit/hyperactivity disorder.
Nature Reviews Disease Primers, .
(doi:10.1038/nrdp.2015.20).
Abstract
Attention-deficit/hyperactivity disorder (ADHD) is a persistent neurodevelopmental disorder that affects 5% of children and adolescents and 2.5% of adults worldwide. Throughout an individual's lifetime, ADHD can increase the risk of other psychiatric disorders, educational and occupational failure, accidents, criminality, social disability and addictions. No single risk factor is necessary or sufficient to cause ADHD. In most cases ADHD arises from several genetic and environmental risk factors that each have a small individual effect and act together to increase susceptibility. The multifactorial causation of ADHD is consistent with the heterogeneity of the disorder, which is shown by its extensive psychiatric co-morbidity, its multiple domains of neurocognitive impairment and the wide range of structural and functional brain anomalies associated with it. The diagnosis of ADHD is reliable and valid when evaluated with standard criteria for psychiatric disorders. Rating scales and clinical interviews facilitate diagnosis and aid screening. The expression of symptoms varies as a function of patient developmental stage and social and academic contexts. Although there are no curative treatments for ADHD, evidenced-based treatments can markedly reduce its symptoms and associated impairments. For example, medications are efficacious and normally well tolerated, and various non-pharmacological approaches are also valuable. Ongoing clinical and neurobiological research holds the promise of advancing diagnostic and therapeutic approaches to ADHD
This record has no associated files available for download.
More information
e-pub ahead of print date: 6 August 2015
Published date: 6 August 2015
Organisations:
Clinical Neuroscience
Identifiers
Local EPrints ID: 381580
URI: http://eprints.soton.ac.uk/id/eprint/381580
PURE UUID: b8fd3190-a29e-407b-a758-ebed542e4c73
Catalogue record
Date deposited: 19 Oct 2015 13:03
Last modified: 14 Mar 2024 21:17
Export record
Altmetrics
Contributors
Author:
Stephen V. Faraone
Author:
Philip Asherson
Author:
Tobias Banaschewski
Author:
Joseph Biederman
Author:
Jan K. Buitelaar
Author:
Josep Antoni Ramos-Quiroga
Author:
Luis Augusto Rohde
Author:
Edmund J. S. Sonuga-Barke
Author:
Rosemary Tannock
Author:
Barbara Franke
Download statistics
Downloads from ePrints over the past year. Other digital versions may also be available to download e.g. from the publisher's website.
View more statistics